Co-Authors
This is a "connection" page, showing publications co-authored by Péter Hegyi and Szilárd Váncsa.
Connection Strength
2.087
-
Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases. Viruses. 2021 03 19; 13(3).
Score: 0.935
-
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis. Viruses. 2021 04 30; 13(5).
Score: 0.236
-
Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis. Front Med (Lausanne). 2021; 8:626425.
Score: 0.233
-
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne). 2020; 7:572115.
Score: 0.228
-
Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial. Trials. 2020 Sep 29; 21(1):809.
Score: 0.226
-
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies. Front Pharmacol. 2021; 12:619524.
Score: 0.058
-
Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials. Trials. 2021 Feb 01; 22(1):112.
Score: 0.058
-
Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020 10; 21(10):e13095.
Score: 0.056
-
The negative impact of comorbidities on the disease course of COVID-19. Intensive Care Med. 2020 09; 46(9):1784-1786.
Score: 0.056